Efficacy and Safety of ART002, a Single-dose Gene Editing Therapy, in Patients with Severe Heterozygous Familial Hypercholesterolemia

Leqvio (inclisiran) - Novartis

ART002 - AccurEdit Therapeutics

https://www.sciencedirect.com/science/article/pii/S1525001625003028

Pinfang Kang 1; Yi Zhao 1; Qin Gao 2; Qing Chen 1; Ying Tang 1; Meiyang Xu 1; Ziyi Chen 3; Hongju Wang 1; Wenjuan Wu 3; Han Qiu 4; Jialin Tao 5; Yongzhong Wang 6; Ningru Zhang 1; Bi Tang 1; Huan Zhou 1

Apr 10, 2025